Bruker Corporation Market Cap ($5.82 Billion)
Market Cap & Net Worth: Bruker Corporation (BRKR)
Bruker Corporation market cap. Bruker Corporation (NASDAQ:BRKR) has a market capitalization of $5.82 Billion ($5.82 Billion) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3126 globally and #1126 in its home market, demonstrating a -0.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bruker Corporation's stock price $57.07 by its total outstanding shares 152219250 (152.22 Million). Also see cash efficiency ratio of Bruker Corporation for how efficiently the company converts equity into cash flow.
Bruker Corporation Market Cap History (2015–2026)
Bruker Corporation market cap history from 2015 to 2026. Data shows growth from $3.57 Billion to $8.69 Billion (11.28% CAGR). Check Bruker Corporation stock quote for real-time trading data and today's change.
Index Memberships
Bruker Corporation is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Biotechnology
BTK
|
$1.06 Trillion | 0.55% | #24 of 30 |
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.22% | #79 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.01% | #352 of 3165 |
|
S&P Midcap 400
MID
|
$3.34 Trillion | 0.17% | #234 of 401 |
Weight: Bruker Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bruker Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bruker Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BRKR net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.09x
Bruker Corporation's market cap is 2.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.13 Billion | $1.61 Billion | $153.60 Million | 1.95x | 20.41x |
| 2017 | $5.11 Billion | $1.77 Billion | $78.60 Million | 2.89x | 64.98x |
| 2018 | $4.45 Billion | $1.90 Billion | $179.70 Million | 2.35x | 24.78x |
| 2019 | $7.65 Billion | $2.07 Billion | $197.20 Million | 3.69x | 38.80x |
| 2020 | $8.15 Billion | $1.99 Billion | $157.80 Million | 4.10x | 51.68x |
| 2021 | $12.67 Billion | $2.42 Billion | $277.10 Million | 5.24x | 45.72x |
| 2022 | $10.35 Billion | $2.53 Billion | $296.60 Million | 4.09x | 34.90x |
| 2023 | $11.16 Billion | $2.96 Billion | $427.20 Million | 3.77x | 26.13x |
| 2024 | $8.92 Billion | $3.37 Billion | $113.10 Million | 2.65x | 78.90x |
| 2025 | $7.17 Billion | $3.44 Billion | -$8.60 Million | 2.09x | N/A |
Competitor Companies of BRKR by Market Capitalization
Companies near Bruker Corporation in the global market cap rankings as of November 1, 2026. Also see BRKR total asset value for a full breakdown of the balance sheet.
Key companies related to Bruker Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Bruker Corporation (2015–2026)
Market capitalization of Bruker Corporation from 2015 to today. Between 2015 and today, Bruker Corporation's market cap moved from $3.57 Billion to $ 8.69 Billion, with a yearly change of 11.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.69 Billion | +21.14% |
| 2025 | $7.17 Billion | -19.63% |
| 2024 | $8.92 Billion | -20.06% |
| 2023 | $11.16 Billion | +7.82% |
| 2022 | $10.35 Billion | -18.29% |
| 2021 | $12.67 Billion | +55.35% |
| 2020 | $8.15 Billion | +6.58% |
| 2019 | $7.65 Billion | +71.85% |
| 2018 | $4.45 Billion | -12.82% |
| 2017 | $5.11 Billion | +62.96% |
| 2016 | $3.13 Billion | -12.16% |
| 2015 | $3.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Bruker Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.82 Billion USD |
| MoneyControl | $5.82 Billion USD |
| MarketWatch | $5.82 Billion USD |
| marketcap.company | $5.82 Billion USD |
| Reuters | $5.82 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more